Suppr超能文献

镰状细胞肾病的患病率及其预测因素:一项单中心研究

Prevalence and predictors of Sickle Cell Nephropathy A single-center experience.

机构信息

Internal Medicine Department, College of Medicine, King Faisal University, Al- Ahsa, Saudi Arabia.

Nephrology Unit, Internal Medicine Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.

出版信息

Sci Rep. 2024 Nov 15;14(1):28215. doi: 10.1038/s41598-024-79345-8.

Abstract

Sickle cell disease (SCD) is the most common monogenic disorder in Saudi Arabia, which associates with an increased risk of organs damage, including the kidney. The aim of this study is to investigate the prevalence and predictors of sickle cell nephropathy (SCN) in the Saudi population. A retrospective study was conducted from April to October 2023, and included 343 adult patients with SCD who were recruited from the hereditary blood diseases center (HBDC), Al-Ahsa, Saudi Arabia. Spot protein-to-creatinine ratio was measured and glomerular filtration rate (GFR) was estimated from serum creatinine using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. As per KIDGO guidelines, CKD was diagnosed in 93 (27.1%) patients. Based on the CKD-EPI equation, 2% of patients had low GFR (eGFR < 60mL/min), 28.3% had high GFR (eGFR > 140 mL/min), and 69.7% had normal GFR. Among SCD patients, proteinuria was observed in 26.5% of the patients. SCD patients with CKD were significantly older than non-CKD patients (p < 0.001) and had higher prevalence of diabetes mellitus (DM) and hypertension (HTN) (p = 0.045 and 0.001 respectively). The multivariate analysis showed that age (P = 0.001; OR 1.035; 95% CI 1.014-1.056) and low hemoglobin level (p = 0.034; OR -0.851; 95% CI 0.721-0.980) were independent risk factors for the development of SCN. Nephropathy is a common complication among patients with SCD as early as the third decade of life, although they remain asymptomatic. Advances in age and low hemoglobin levels are the main predictors of nephropathy. In addition, SCD patients with coexistent comorbidities, particularly DM and HTN, were at increased risk of developing kidney disease.

摘要

镰状细胞病(SCD)是沙特阿拉伯最常见的单基因疾病,与器官损伤风险增加有关,包括肾脏。本研究旨在调查沙特人群中镰状细胞肾病(SCN)的患病率和预测因素。一项回顾性研究于 2023 年 4 月至 10 月进行,共纳入 343 名来自沙特阿拉伯阿赫萨遗传性血液疾病中心(HBDC)的成年 SCD 患者。测量了尿蛋白与肌酐的比值,并使用慢性肾脏病流行病学合作(CKD-EPI)方程根据血清肌酐估计肾小球滤过率(GFR)。根据 KIDGO 指南,93 例(27.1%)患者诊断为 CKD。根据 CKD-EPI 方程,2%的患者存在低 GFR(eGFR<60mL/min),28.3%存在高 GFR(eGFR>140mL/min),69.7%存在正常 GFR。在 SCD 患者中,蛋白尿见于 26.5%的患者。与非 CKD 患者相比,SCD 合并 CKD 患者明显更年长(p<0.001),且糖尿病(DM)和高血压(HTN)患病率更高(p=0.045 和 0.001)。多变量分析显示,年龄(P=0.001;OR 1.035;95%CI 1.014-1.056)和低血红蛋白水平(p=0.034;OR-0.851;95%CI 0.721-0.980)是 SCN 发展的独立危险因素。肾病是 SCD 患者早在 30 多岁时就常见的并发症,尽管他们仍然无症状。年龄增长和低血红蛋白水平是肾病的主要预测因素。此外,合并共存合并症,特别是 DM 和 HTN 的 SCD 患者,发生肾脏疾病的风险增加。

相似文献

1
Prevalence and predictors of Sickle Cell Nephropathy A single-center experience.
Sci Rep. 2024 Nov 15;14(1):28215. doi: 10.1038/s41598-024-79345-8.
2
Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.
Am J Kidney Dis. 2019 Jul;74(1):47-55. doi: 10.1053/j.ajkd.2018.12.027. Epub 2019 Feb 21.
4
Proteinuria in patients with sickle cell disease.
Saudi J Kidney Dis Transpl. 2014 Sep;25(5):1038-41. doi: 10.4103/1319-2442.139931.
5
Assessment of renal function in Indian patients with sickle cell disease.
Saudi J Kidney Dis Transpl. 2017 May-Jun;28(3):524-531. doi: 10.4103/1319-2442.206440.
7
Interventions for chronic kidney disease in people with sickle cell disease.
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
8
Interventions for chronic kidney disease in people with sickle cell disease.
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
10
Chronic kidney disease and albuminuria in children with sickle cell disease.
Clin J Am Soc Nephrol. 2011 Nov;6(11):2628-33. doi: 10.2215/CJN.01600211. Epub 2011 Sep 22.

本文引用的文献

1
Renal-Protective Roles of Lipoic Acid in Kidney Disease.
Nutrients. 2023 Apr 1;15(7):1732. doi: 10.3390/nu15071732.
2
Cell and gene therapy for kidney disease.
Nat Rev Nephrol. 2023 Jul;19(7):451-462. doi: 10.1038/s41581-023-00702-3. Epub 2023 Mar 27.
3
Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):266-271. doi: 10.1182/hematology.2022000371.
4
Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury.
Nefrologia (Engl Ed). 2021 Jul-Aug;41(4):373-382. doi: 10.1016/j.nefroe.2021.10.001. Epub 2021 Oct 27.
5
The nephropathy of sickle cell trait and sickle cell disease.
Nat Rev Nephrol. 2022 Jun;18(6):361-377. doi: 10.1038/s41581-022-00540-9. Epub 2022 Feb 21.
6
Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia.
Health Sci Rep. 2021 Nov 9;4(4):e437. doi: 10.1002/hsr2.437. eCollection 2021 Dec.
8
Predictors associated with sickle cell nephropathy: a systematic review.
Rev Assoc Med Bras (1992). 2021 Feb;67(2):313-317. doi: 10.1590/1806-9282.67.02.20200676.
9
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. eCollection 2021.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验